Sample | Title | Value | Rank |
GSM1256964 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 1 | 45.9774 | 70 |
GSM1256965 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 2 | 60.8486 | 73 |
GSM1256966 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 3 | 45.7741 | 70 |
GSM1256967 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 4 | 40.1565 | 66 |
GSM1256980 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 54 before YFV | 36.9495 | 64 |
GSM1256984 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 54 seven days after YFV | 23.4009 | 57 |
GSM1256981 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 55 before YFV | 30.9759 | 62 |
GSM1256985 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 55 seven days after YFV | 58.6891 | 70 |
GSM1256982 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 56 before YFV | 71.3945 | 73 |
GSM1256986 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 56 seven days after YFV | 43.4285 | 67 |
GSM1256983 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 57 before YFV | 72.2827 | 74 |
GSM1256987 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 57 seven days after YFV | 66.3556 | 73 |